Neutralizing Antibodies Against the SARS-CoV-2 Omicron Variant (BA.1) 1 to 18 Weeks After the Second and Third Doses of the BNT162b2 mRNA Vaccine

Ria Lassaunière*, Charlotta Polacek, Anders Frische, Lasse Boding, Susanne Gjørup Sækmose, Morten Rasmussen, Anders Fomsgaard

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskriftLetterForskningpeer review

Abstract

This cohort study examines neutralizing antibodies against the SARS-CoV-2 Omicron variant (BA.1) after the second and third doses of the BNT162b2 mRNA vaccine among Danish adults.

OriginalsprogEngelsk
Artikelnummere2212073
TidsskriftJAMA network open
Vol/bind5
Udgave nummer5
DOI
StatusUdgivet - 13 maj 2022

Fingeraftryk

Udforsk hvilke forskningsemner 'Neutralizing Antibodies Against the SARS-CoV-2 Omicron Variant (BA.1) 1 to 18 Weeks After the Second and Third Doses of the BNT162b2 mRNA Vaccine' indeholder.

Citationsformater